Parrhesia Fermentery is a unique company developing artisanal and healthy fermented beverages and plant-based cheeses. With support from Innolab at Campus Groningen and an Mkb Feasibility Voucher, initiator Floris Glasbeek can take significant steps in the development and scaling of his innovative products. The Mkb Feasibility Voucher is a subsidy that reimburses up to 40% of costs for entrepreneurs in Northern Netherlands to explore the economic and technical feasibility of their innovative ideas in a Northern test environment.
Floris: "We knew what we wanted to create and what qualities our beverages should have. But for real scaling, you need a plan: not just what you make, but also how you make it."
The journey to Parrhesia Fermentery began in 2019 when Floris opened a specialized vape shop in Groningen. His interest in technology, science, and culture led him to fermentation. Recognizing a gap in the soft drink market, he started experimenting with fermented beverages like ginger beer. "Many soft drinks are just sugary water. We aimed to do better," says Floris. This sparked the idea of crafting artisanal fermented beverages.
To test his ideas, he opened a café in Groningen’s city center, doubling as a test kitchen. Customers provided direct feedback, allowing him to refine his recipes. "We pretended to be a cafe, but we were actually a testing laboratory," Floris explains.
"We knew what we wanted to create and what qualities our beverages should have. But for real scaling, you need a plan: not just what you make, but also how you make it."
Floris Glasbeek initiatiator Parrhesia Fermentery
After successful experiments, the next challenge was designing a scalable process for an artisanal product without compromising quality. This is where the Mkb Feasibility Voucher and collaboration with Innolab came into play.
Campus Groningen and Innolab, through business developer Daan van Oldeniel and Sven Stielstra (Innolabs manager), assisted Floris and his team in connecting with the right partners and experts. This enabled access to labs and expertise through the Mkb Feasibility Voucher. Floris: "To create our own testing laboratory, we needed additional knowledge and specialization, which we found at the Campus."
Sven Stielstra mentions that this route wasn’t initially clear-cut. "Initially, the Mkb Feasibility Voucher on Campus was used for companies physically present here, like in Innolab Agrifood. Parrhesia Fermentery fetches knowledge and collaboration from us. After discussing with subsidy provider SNN, it became clear this approach fits perfectly within the guidelines, which I'm very pleased about."
Thanks to the voucher, Parrhesia Fermentery collaborates with specialists such as SG Papertronics and Avebe on campus. Floris: "SG Papertronics provides specialized lab support for tests we can’t do ourselves. They assist with crucial quality measurements like pH and sugar levels, and monitor alcohol content. Their expertise in enzyme research is essential for refining our products."
At Avebe, Parrhesia gains insights into production. Floris: "Avebe, especially Marc Laus, offers valuable advice on scaling up. They help us plan the steps needed to expand production and provide facilities for experimentation. Understanding the challenges is crucial before we move into large-scale production."
"The real collaboration in labs and production spaces will intensify in the coming months," says Floris. "For now, our focus is on networking and exchanging ideas, but later this year, we'll apply this knowledge in practice."
With support from Innolab, the campus, and the right partners, Parrhesia Fermentery's future looks promising. The next months will be dedicated to process development, followed by testing production on a larger scale. "Our next step is ensuring complete control over our production process, so we can make an impact not just locally, but potentially nationally and internationally." Thanks to Innolab and the Mkb Feasibility Voucher, Parrhesia Fermentery is well on its way to becoming a leading player in the world of living fermented foods and beverages.
About de Mkb Haalbaarheidsvoucher
The Mkb Haalbaarheidsvoucher (Mkb Feasibility Voucher) is a subsidy for innovative entrepreneurs in Groningen, Drenthe, and Friesland. This voucher allows companies to explore the economic and technical feasibility of their ideas at a Northern test environment, such as Innolab Engineering, Innolab Chemistry, Innolab Agrifood, or Zernike Advanced Processing (ZAP) on Campus Groningen.
Made possible by the ERDF (European Regional Development Fund) program and implemented by the Northern Netherlands Cooperation (SNN), the subsidy reimburses 40% of costs for feasibility studies, including wages, lab and demo room rentals, materials, and advice. Entrepreneurs can apply until Sunday, November 30, 2025 (5:00 PM) for an Mkb Feasibility Voucher.
About de Innolabs op Campus Groningen
Innolabs at Campus Groningen provide innovative entrepreneurs, students, and researchers with space to develop and test ideas, offering lab space, business support, and networking opportunities.
Innolab Agrifood, located in the Innovation Center Avebe, supports agrifood startups with lab facilities and advice on business development, strategy, and patenting.
Innolab Chemistry & Engineering (located in the Innovation Center Chemistry and Engineering) offers flexible lab space, shared analytical capacities, and support for chemical and technical startups.
With modular labs, advanced equipment, and strong connections with the University of Groningen, Hanze University of Applied Sciences, UMCG (University Medical Center Groningen), and the business community, Innolabs are the hub for innovation and entrepreneurship.
Op zondag 31 mei 2026 staat Groningen in het teken van sport, doorzettingsvermogen en betrokkenheid. Tussen alle lopers is ook het herkenbare roze van Vrienden Beatrix Kinderziekenhuis zichtbaar.
The LIFE Cooperative, part of the Northern Netherlands life sciences ecosystem at Campus Groningen, is organizing the Dutch Medicines Winter Afternoon together with FIGON on Thursday, 26 February. This fully booked event brings together leading scientists and industry experts to explore the latest developments in innovative medicines and advanced drug delivery. Read the full article as published by the LIFE Cooperative.National Attention for Sold-Out Dutch Medicines Winter Afternoon: Innovative Medicines and Advanced Drug Delivery Take Center Stage in Groningen Innovation in medicines takes center stage on Thursday, 26 February during the Dutch Medicines Winter Afternoon, an inspiring event organized by FIGON (Federation for Innovative Drug Research Netherlands) in collaboration with the LIFE Cooperative. “We are extremely proud of the strong line-up at this event, bringing together leading experts from science and industry to explore the frontiers of drug development. The fact that registrations are already fully booked underlines the great importance of this event for the life sciences ecosystem, and in particular for the Northern Netherlands,” says Ronald Hesse, Director of the LIFE Cooperative. The Dutch Medicines Winter Afternoon brings together scientists, innovators, and professionals from across the Netherlands for an afternoon of insights, knowledge exchange, and networking opportunities. The speaker line-up features experts from both academia and industry. This event is already fully booked. Interested in joining the waiting list? Please email: amber@lifecooperative.nlConnecting force The afternoon will be opened by Prof. Klaas Poelstra of the University of Groningen (RUG), Chair of FIGON, who will outline the importance of innovative drug development in the Netherlands. This will be followed by an introduction by Robert Hof on behalf of the LIFE Cooperative, highlighting the cooperative’s role as a connecting force within the regional ecosystem. The first session block before the break focuses on innovation in drug delivery systems. Rob Steendam (CTO, InnoCore) will discuss the development of long-acting SynBiosys® microspheres for controlled and sustained drug release. Jaap Wieling (CEO, PureIMS) will present the potential of dry-powder inhalation via the Cyclops® technology for both pulmonary and systemic indications. From an academic perspective, Prof. Marleen Kamperman (University of Groningen) will explore the potential of polyelectrolyte coacervates as innovative drug delivery platforms.Deep dive After the break, the focus shifts to advanced nanomedicines and clinical development strategies. Dr. Flávia Sousa (RUG) will present her work on polymer-based nanomedicines for the delivery of biotherapeutics to the brain. Dr. Ad Roffel (ICON plc, Groningen) will address mass balance and absolute bioavailability studies with ¹⁴C-labeled drugs in humans, an essential component of clinical drug development. Prof. Erik Frijlink (RUG) will reflect on the value of innovation within both established and advanced drug delivery systems, placing technological progress in a broader pharmaceutical context. Finally, Prof. Helder Santos (RUG) will demonstrate how nanomedicines are being used for RNA delivery in myocardial infarction repair, a promising development in cardiovascular therapy. “We are extremely proud of the strong line-up at this event, bringing together leading experts from science and industry to explore the frontiers of drug development. The fact that registrations are already fully booked underlines the great importance of this event for the life sciences ecosystem, and in particular for the Northern Netherlands." - Ronald Hesse, director LIFE CooperativeClosing and networking The afternoon will conclude with a contribution by Peter Ketelaar (LIFE Cooperative), followed by closing remarks from Prof. Klaas Poelstra. Participants will then have the opportunity to connect and continue discussions during the networking reception. Hesse looks forward to the event: “With this event, FIGON and the LIFE Cooperative underline the strength of collaboration between academia, industry, and clinical practice. The Dutch Medicines Winter Afternoon promises not only to be an inspiring afternoon, but also to provide momentum for further innovation and collaboration within the Northern Netherlands life sciences ecosystem.” Text: lifecooperative.nlPhotographer: Casper Maas
The master plan for the Healthy Ageing Campus has officially been approved! This marks an important step in developing the campus as a hub for knowledge, innovation, and collaboration. With a focus on greenery, health, and connection to the city, the campus will become a vibrant environment where research, education, healthcare, and business come together. The vision provides space for new laboratories, building renovations, meeting places, and closer collaboration between UMCG, RUG, and the business community. Read the whole article by the UMCG below.Green light for the Healthy Ageing Campus Master Plan On Wednesday, 18 February 2026, the Groningen City Council formally approved the master plan for the Healthy Ageing Campus. This is a major milestone, as the plan provides the framework for the campus’s further development and its integration with the surrounding area. At the end of last year, the University of Groningen (RUG), the University Medical Center Groningen (UMCG), and the City of Groningen presented an ambitious, future-proof plan for the campus. Shared ambitions have been translated into coherent spatial and programmatic guidelines for current and future developments. In other words: how much space is available for which functions on the campus, and where is the most suitable location for them? The renewed campus will: Provide space for knowledge, innovation, and collaboration, encouraging interaction between disciplines and people; Connect with the city, making the campus a natural part of Groningen life; Be a healthy and sustainable environment, with attention to greenery, physical activity, wellbeing, and a living environment that supports health; Be lively and accessible, bringing together living, working, research, studying, and healthcare.Next steps The master plan is not only a blueprint for the future, but also a concrete step toward further developing the current campus. Construction and renovation on the UMCG and RUG grounds are ongoing, and each project must now be assessed to determine what is possible. With the approval of this master plan, the way is cleared for follow-up decisions, including applying for demolition and building permits and further project development within the area. Upcoming projects include: The construction of the Central Laboratory for Diagnostics and Research (CLDR): a new laboratory building on the site of the former UCP building. This building will bring together various laboratories in one location to improve collaboration. Relocating laboratories from the Central Medical Complex is also necessary for the renovation and expansion of several hospital departments; Renovation and future-proofing of existing UMCG and RUG buildings, with attention to sustainability, flexibility, and integration with the heating/cooling system; Making the campus greener and more accessible, creating new meeting places and better connections to surrounding public spaces; Creating space for campus-related business activities, strengthening collaboration between UMCG, RUG, and the private sector.Municipality explores the future of DOT Initially, the master plan covered the area between Petrus Campersingel and Oostersingel, from Hanzeplein to the Oosterhamrikkanaal. In the newly approved plan, the Bodenterrein site has been separated, as the municipality is investigating the costs of possibly preserving DOT. More information on this will be available later this year. Read more about the Master Plan.Source text and pictures: umcg.nl